Jul 10 |
Why Is Longeveron Stock Soaring On Wednesday?
|
Jul 10 |
Longeveron scores RMAT designation for Alzheimer’s cell therapy
|
Jul 10 |
Longeveron surges on key FDA designation for Alzheimer’s drug
|
Jul 10 |
LGVN’s Alzheimer's Treatment Gets FDA Boost
|
Jul 10 |
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
|
Jul 9 |
Neha Motwani Elected to Longeveron® Board of Directors
|
Jul 8 |
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
|
Jun 28 |
Longeveron files to sell 3.56M shares of Class A common stock for holders
|
Jun 21 |
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
|
Jun 19 |
3 Penny Stocks Poised to Turn Pocket Change Into a Small Fortune by 2028
|